Global and China Finasteride Market Insights, Forecast to 2027

Publisher Name :
Date: 22-Oct-2021
No. of pages: 140
Inquire Before Buying

Finasteride market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Finasteride market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Finasteride market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- 1mg Tablet

- 5mg Tablet

Segment by Application

- Medical Uses

- Application 2

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - U.A.E

By Company

- Merck

- Actavis

- Sandoz

- Teva Pharmaceuticals

- Cipla

- RelonChem

- Dr. Reddy

- Accord Pharmaceuticals

- Henan Topfond

- Zhejiang CONBA Pharmaceutical

- Shandong Renhetang Pharmaceutical

- Guangdong Eashu Pharmacetical

Global and China Finasteride Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Finasteride Product Introduction
1.2 Market by Type
1.2.1 Global Finasteride Market Size Growth Rate by Type
1.2.2 1mg Tablet
1.2.3 5mg Tablet
1.3 Market by Application
1.3.1 Global Finasteride Market Size Growth Rate by Application
1.3.2 Medical Uses
1.3.3 Application 2
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Finasteride Market Size, Estimates and Forecasts
2.1.1 Global Finasteride Revenue 2016-2027
2.1.2 Global Finasteride Sales 2016-2027
2.2 Global Finasteride, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Finasteride Historical Market Size by Region (2016-2021)
2.3.1 Global Finasteride Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Finasteride Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Finasteride Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Finasteride Sales Forecast by Region (2022-2027)
2.4.2 Global Finasteride Revenue Forecast by Region (2022-2027)
3 Global Finasteride Competitor Landscape by Players
3.1 Global Top Finasteride Manufacturers by Sales
3.1.1 Global Finasteride Sales by Manufacturer (2016-2021)
3.1.2 Global Finasteride Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Finasteride Manufacturers by Revenue
3.2.1 Key Finasteride Manufacturers Covered: Ranking by Revenue
3.2.2 Global Finasteride Revenue by Manufacturers (2016-2021)
3.2.3 Global Finasteride Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Finasteride Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Finasteride Revenue in 2020
3.2.6 Global Finasteride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Finasteride Price by Manufacturers
3.4 Global Finasteride Manufacturing Base Distribution, Product Types
3.4.1 Finasteride Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Finasteride Product Type
3.4.3 Date of International Manufacturers Enter into Finasteride Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Finasteride Market Size by Type (2016-2021)
4.1.1 Global Finasteride Sales by Type (2016-2021)
4.1.2 Global Finasteride Revenue by Type (2016-2021)
4.1.3 Finasteride Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Finasteride Market Size Forecast by Type (2022-2027)
4.2.1 Global Finasteride Sales Forecast by Type (2022-2027)
4.2.2 Global Finasteride Revenue Forecast by Type (2022-2027)
4.2.3 Finasteride Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Finasteride Market Size by Application (2016-2021)
5.1.1 Global Finasteride Sales by Application (2016-2021)
5.1.2 Global Finasteride Revenue by Application (2016-2021)
5.1.3 Finasteride Price by Application (2016-2021)
5.2 Finasteride Market Size Forecast by Application (2022-2027)
5.2.1 Global Finasteride Sales Forecast by Application (2022-2027)
5.2.2 Global Finasteride Revenue Forecast by Application (2022-2027)
5.2.3 Global Finasteride Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Finasteride Market Size YoY Growth 2016-2027
6.1.1 China Finasteride Sales YoY Growth 2016-2027
6.1.2 China Finasteride Revenue YoY Growth 2016-2027
6.1.3 China Finasteride Market Share in Global Market 2016-2027
6.2 China Finasteride Market Size by Players (International and Local Players)
6.2.1 China Top Finasteride Players by Sales (2016-2021)
6.2.2 China Top Finasteride Players by Revenue (2016-2021)
6.3 China Finasteride Historic Market Review by Type (2016-2021)
6.3.1 China Finasteride Sales Market Share by Type (2016-2021)
6.3.2 China Finasteride Revenue Market Share by Type (2016-2021)
6.3.3 China Finasteride Price by Type (2016-2021)
6.4 China Finasteride Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Finasteride Sales Forecast by Type (2022-2027)
6.4.2 China Finasteride Revenue Forecast by Type (2022-2027)
6.4.3 China Finasteride Price Forecast by Type (2022-2027)
6.5 China Finasteride Historic Market Review by Application (2016-2021)
6.5.1 China Finasteride Sales Market Share by Application (2016-2021)
6.5.2 China Finasteride Revenue Market Share by Application (2016-2021)
6.5.3 China Finasteride Price by Application (2016-2021)
6.6 China Finasteride Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Finasteride Sales Forecast by Application (2022-2027)
6.6.2 China Finasteride Revenue Forecast by Application (2022-2027)
6.6.3 China Finasteride Price Forecast by Application (2022-2027)
7 North America
7.1 North America Finasteride Market Size YoY Growth 2016-2027
7.2 North America Finasteride Market Facts & Figures by Country
7.2.1 North America Finasteride Sales by Country (2016-2021)
7.2.2 North America Finasteride Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Finasteride Market Size YoY Growth 2016-2027
8.2 Asia Pacific Finasteride Market Facts & Figures by Region
8.2.1 Asia Pacific Finasteride Sales by Region (2016-2021)
8.2.2 Asia Pacific Finasteride Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Finasteride Market Size YoY Growth 2016-2027
9.2 Europe Finasteride Market Facts & Figures by Country
9.2.1 Europe Finasteride Sales by Country (2016-2021)
9.2.2 Europe Finasteride Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Finasteride Market Size YoY Growth 2016-2027
10.2 Latin America Finasteride Market Facts & Figures by Country
10.2.1 Latin America Finasteride Sales by Country (2016-2021)
10.2.2 Latin America Finasteride Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Finasteride Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Finasteride Market Facts & Figures by Country
11.2.1 Middle East and Africa Finasteride Sales by Country (2016-2021)
11.2.2 Middle East and Africa Finasteride Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Merck
12.1.1 Merck Corporation Information
12.1.2 Merck Description and Business Overview
12.1.3 Merck Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Merck Finasteride Products Offered
12.1.5 Merck Recent Development
12.2 Actavis
12.2.1 Actavis Corporation Information
12.2.2 Actavis Description and Business Overview
12.2.3 Actavis Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Actavis Finasteride Products Offered
12.2.5 Actavis Recent Development
12.3 Sandoz
12.3.1 Sandoz Corporation Information
12.3.2 Sandoz Description and Business Overview
12.3.3 Sandoz Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Sandoz Finasteride Products Offered
12.3.5 Sandoz Recent Development
12.4 Teva Pharmaceuticals
12.4.1 Teva Pharmaceuticals Corporation Information
12.4.2 Teva Pharmaceuticals Description and Business Overview
12.4.3 Teva Pharmaceuticals Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Teva Pharmaceuticals Finasteride Products Offered
12.4.5 Teva Pharmaceuticals Recent Development
12.5 Cipla
12.5.1 Cipla Corporation Information
12.5.2 Cipla Description and Business Overview
12.5.3 Cipla Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Cipla Finasteride Products Offered
12.5.5 Cipla Recent Development
12.6 RelonChem
12.6.1 RelonChem Corporation Information
12.6.2 RelonChem Description and Business Overview
12.6.3 RelonChem Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.6.4 RelonChem Finasteride Products Offered
12.6.5 RelonChem Recent Development
12.7 Dr. Reddy
12.7.1 Dr. Reddy Corporation Information
12.7.2 Dr. Reddy Description and Business Overview
12.7.3 Dr. Reddy Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Dr. Reddy Finasteride Products Offered
12.7.5 Dr. Reddy Recent Development
12.8 Accord Pharmaceuticals
12.8.1 Accord Pharmaceuticals Corporation Information
12.8.2 Accord Pharmaceuticals Description and Business Overview
12.8.3 Accord Pharmaceuticals Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Accord Pharmaceuticals Finasteride Products Offered
12.8.5 Accord Pharmaceuticals Recent Development
12.9 Henan Topfond
12.9.1 Henan Topfond Corporation Information
12.9.2 Henan Topfond Description and Business Overview
12.9.3 Henan Topfond Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Henan Topfond Finasteride Products Offered
12.9.5 Henan Topfond Recent Development
12.10 Zhejiang CONBA Pharmaceutical
12.10.1 Zhejiang CONBA Pharmaceutical Corporation Information
12.10.2 Zhejiang CONBA Pharmaceutical Description and Business Overview
12.10.3 Zhejiang CONBA Pharmaceutical Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Zhejiang CONBA Pharmaceutical Finasteride Products Offered
12.10.5 Zhejiang CONBA Pharmaceutical Recent Development
12.11 Merck
12.11.1 Merck Corporation Information
12.11.2 Merck Description and Business Overview
12.11.3 Merck Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Merck Finasteride Products Offered
12.11.5 Merck Recent Development
12.12 Guangdong Eashu Pharmacetical
12.12.1 Guangdong Eashu Pharmacetical Corporation Information
12.12.2 Guangdong Eashu Pharmacetical Description and Business Overview
12.12.3 Guangdong Eashu Pharmacetical Finasteride Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Guangdong Eashu Pharmacetical Products Offered
12.12.5 Guangdong Eashu Pharmacetical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Finasteride Industry Trends
13.2 Finasteride Market Drivers
13.3 Finasteride Market Challenges
13.4 Finasteride Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Finasteride Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Finasteride Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of 1mg Tablet
Table 3. Major Manufacturers of 5mg Tablet
Table 4. Global Finasteride Market Size Growth Rate by Application (2021-2027) & (MT)
Table 5. Global Finasteride Market Size by Region (MT) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Finasteride Sales by Regions (2016-2021) & (MT)
Table 7. Global Finasteride Sales Market Share by Regions (2016-2021)
Table 8. Global Finasteride Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Finasteride Sales Forecast by Region (2022-2027) & (MT)
Table 10. Global Finasteride Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Finasteride Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Finasteride Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Finasteride Sales by Manufacturers (2016-2021) (MT)
Table 14. Global Finasteride Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Finasteride Manufacturers by Revenue (US$ Million) in 2020
Table 16. Finasteride Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Finasteride Revenue Share by Manufacturers (2016-2021)
Table 18. Global Finasteride Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Finasteride by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Finasteride as of 2020)
Table 20. Key Manufacturers Finasteride Price (2016-2021) (USD/Kg)
Table 21. Finasteride Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Finasteride Product Type
Table 23. Date of International Manufacturers Enter into Finasteride Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Finasteride Sales by Type (2016-2021) (MT)
Table 26. Global Finasteride Sales Share by Type (2016-2021)
Table 27. Global Finasteride Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Finasteride Revenue Share by Type (2016-2021)
Table 29. Finasteride Average Selling Price (ASP) by Type (2016-2021) & (USD/Kg)
Table 30. Global Finasteride Sales Forecast by Type (2022-2027) & (MT)
Table 31. Global Finasteride Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Finasteride Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Finasteride Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Finasteride Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Kg)
Table 35. Global Finasteride Sales by Application (2016-2021) (MT)
Table 36. Global Finasteride Sales Share by Application (2016-2021)
Table 37. Global Finasteride Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Finasteride Revenue Share by Application (2016-2021)
Table 39. Finasteride Average Selling Price (ASP) by Application (2016-2021) & (USD/Kg)
Table 40. Global Finasteride Sales Forecast by Application (2022-2027) & (MT)
Table 41. Global Finasteride Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Finasteride Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Finasteride Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Finasteride Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Kg)
Table 45. China Finasteride Sales (MT) of Key Companies (2016-2021)
Table 46. China Finasteride Sales Share by Company (2016-2021)
Table 47. China Finasteride Revenue (US$ Million) by Company (2016-2021)
Table 48. China Finasteride Revenue Share by Company (2016-2021)
Table 49. China Finasteride Sales (MT) by Type (2016-2021)
Table 50. China Finasteride Sales Share by Type (2016-2021)
Table 51. China Finasteride Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. China Finasteride Price (USD/Kg) by Type (2016-2021)
Table 53. China Finasteride Sales (MT) by Type (2022-2027)
Table 54. China Finasteride Sales Share by Type (2022-2027)
Table 55. China Finasteride Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. China Finasteride Revenue Share by Type (2022-2027)
Table 57. China Finasteride Price (USD/Kg) by Type (2022-2027)
Table 58. China Finasteride Sales (MT) by Application (2016-2021)
Table 59. China Finasteride Sales Share by Application (2016-2021)
Table 60. China Finasteride Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. China Finasteride Price (USD/Kg) by Application (2016-2021)
Table 62. China Finasteride Sales (MT) by Application (2022-2027)
Table 63. China Finasteride Sales Share by Application (2022-2027)
Table 64. China Finasteride Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. China Finasteride Revenue Share by Application (2022-2027)
Table 66. China Finasteride Price (USD/Kg) by Application (2022-2027)
Table 67. North America Finasteride Sales by Country (2016-2021) & (MT)
Table 68. North America Finasteride Sales Market Share by Country (2016-2021)
Table 69. North America Finasteride Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Finasteride Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Finasteride Sales by Region (2016-2021) & (MT)
Table 72. Asia Pacific Finasteride Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Finasteride Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Finasteride Revenue Market Share by Region (2016-2021)
Table 75. Europe Finasteride Sales by Country (2016-2021) & (MT)
Table 76. Europe Finasteride Sales Market Share by Country (2016-2021)
Table 77. Europe Finasteride Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Finasteride Revenue Market Share by Country (2016-2021)
Table 79. Latin America Finasteride Sales by Country (2016-2021) & (MT)
Table 80. Latin America Finasteride Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Finasteride Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Finasteride Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Finasteride Sales by Country (2016-2021) & (MT)
Table 84. Middle East and Africa Finasteride Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Finasteride Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Finasteride Revenue Market Share by Country (2016-2021)
Table 87. Merck Corporation Information
Table 88. Merck Description and Business Overview
Table 89. Merck Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 90. Merck Finasteride Product
Table 91. Merck Recent Development
Table 92. Actavis Corporation Information
Table 93. Actavis Description and Business Overview
Table 94. Actavis Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 95. Actavis Product
Table 96. Actavis Recent Development
Table 97. Sandoz Corporation Information
Table 98. Sandoz Description and Business Overview
Table 99. Sandoz Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 100. Sandoz Product
Table 101. Sandoz Recent Development
Table 102. Teva Pharmaceuticals Corporation Information
Table 103. Teva Pharmaceuticals Description and Business Overview
Table 104. Teva Pharmaceuticals Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 105. Teva Pharmaceuticals Product
Table 106. Teva Pharmaceuticals Recent Development
Table 107. Cipla Corporation Information
Table 108. Cipla Description and Business Overview
Table 109. Cipla Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 110. Cipla Product
Table 111. Cipla Recent Development
Table 112. RelonChem Corporation Information
Table 113. RelonChem Description and Business Overview
Table 114. RelonChem Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 115. RelonChem Product
Table 116. RelonChem Recent Development
Table 117. Dr. Reddy Corporation Information
Table 118. Dr. Reddy Description and Business Overview
Table 119. Dr. Reddy Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 120. Dr. Reddy Product
Table 121. Dr. Reddy Recent Development
Table 122. Accord Pharmaceuticals Corporation Information
Table 123. Accord Pharmaceuticals Description and Business Overview
Table 124. Accord Pharmaceuticals Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 125. Accord Pharmaceuticals Product
Table 126. Accord Pharmaceuticals Recent Development
Table 127. Henan Topfond Corporation Information
Table 128. Henan Topfond Description and Business Overview
Table 129. Henan Topfond Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 130. Henan Topfond Product
Table 131. Henan Topfond Recent Development
Table 132. Zhejiang CONBA Pharmaceutical Corporation Information
Table 133. Zhejiang CONBA Pharmaceutical Description and Business Overview
Table 134. Zhejiang CONBA Pharmaceutical Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 135. Zhejiang CONBA Pharmaceutical Product
Table 136. Zhejiang CONBA Pharmaceutical Recent Development
Table 137. Shandong Renhetang Pharmaceutical Corporation Information
Table 138. Shandong Renhetang Pharmaceutical Description and Business Overview
Table 139. Shandong Renhetang Pharmaceutical Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 140. Shandong Renhetang Pharmaceutical Product
Table 141. Shandong Renhetang Pharmaceutical Recent Development
Table 142. Guangdong Eashu Pharmacetical Corporation Information
Table 143. Guangdong Eashu Pharmacetical Description and Business Overview
Table 144. Guangdong Eashu Pharmacetical Finasteride Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2016-2021)
Table 145. Guangdong Eashu Pharmacetical Product
Table 146. Guangdong Eashu Pharmacetical Recent Development
Table 147. Finasteride Market Trends
Table 148. Finasteride Market Drivers
Table 149. Finasteride Market Challenges
Table 150. Finasteride Market Restraints
Table 151. Finasteride Customers List
Table 152. Finasteride Distributors List
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Finasteride Product Picture
Figure 2. Global Finasteride Sales Market Share by Type in 2020 & 2027
Figure 3. 1mg Tablet Product Picture
Figure 4. 5mg Tablet Product Picture
Figure 5. Global Finasteride Sales Market Share by Application in 2020 & 2027
Figure 6. Medical Uses
Figure 7. Application 2
Figure 8. Finasteride Report Years Considered
Figure 9. Global Finasteride Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Finasteride Market Size 2016-2027 (US$ Million)
Figure 11. Global Finasteride Sales 2016-2027 (MT)
Figure 12. Global Finasteride Market Size Market Share by Region: 2021 Versus 2027
Figure 13. Global Finasteride Sales Market Share by Region (2016-2021)
Figure 14. Global Finasteride Sales Market Share by Region in 2020
Figure 15. Global Finasteride Revenue Market Share by Region (2016-2021)
Figure 16. Global Finasteride Revenue Market Share by Region in 2020
Figure 17. Global Finasteride Sales Share by Manufacturer in 2020
Figure 18. The Top 10 and 5 Players Market Share by Finasteride Revenue in 2020
Figure 19. Finasteride Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 20. Global Finasteride Sales Market Share by Type (2016-2021)
Figure 21. Global Finasteride Sales Market Share by Type in 2020
Figure 22. Global Finasteride Revenue Market Share by Type (2016-2021)
Figure 23. Global Finasteride Revenue Market Share by Type in 2020
Figure 24. Global Finasteride Sales Market Share by Application (2016-2021)
Figure 25. Global Finasteride Sales Market Share by Application in 2020
Figure 26. Global Finasteride Revenue Market Share by Application (2016-2021)
Figure 27. Global Finasteride Revenue Market Share by Application in 2020
Figure 28. China Finasteride Sales Growth Rate 2016-2027 (MT)
Figure 29. China Finasteride Revenue Growth Rate 2016-2027 (US$ Million)
Figure 30. China Finasteride Market Share in Global Market 2016-2027
Figure 31. China 5 and 10 Largest Finasteride Players Market Share by Revenue in Finasteride in 2020
Figure 32. China Finasteride Revenue Share by Type (2016-2021)
Figure 33. China Finasteride Revenue Growth Rate by Type in 2016 & 2020
Figure 34. China Finasteride Revenue Share by Application (2016-2021)
Figure 35. China Finasteride Revenue Growth Rate by Application in 2016 & 2020
Figure 36. North America Finasteride Sales Growth Rate 2016-2021 (MT)
Figure 37. North America Finasteride Revenue Growth Rate 2016-2021 (US$ Million)
Figure 38. North America Finasteride Sales Market Share by Country in 2020
Figure 39. North America Finasteride Revenue Market Share by Country in 2020
Figure 40. U.S. Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 41. U.S. Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Canada Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 43. Canada Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Europe Finasteride Sales Growth Rate 2016-2021 (MT)
Figure 45. Europe Finasteride Revenue Growth Rate 2016-2021 (US$ Million)
Figure 46. Europe Finasteride Sales Market Share by Country in 2020
Figure 47. Europe Finasteride Revenue Market Share by Country in 2020
Figure 48. Germany Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 49. Germany Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. France Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 51. France Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 52. U.K. Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 53. U.K. Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 54. Italy Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 55. Italy Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. Russia Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 57. Russia Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. Asia Pacific Finasteride Sales Growth Rate 2016-2021 (MT)
Figure 59. Asia Pacific Finasteride Revenue Growth Rate 2016-2021 (US$ Million)
Figure 60. Asia Pacific Finasteride Sales Market Share by Region in 2020
Figure 61. Asia Pacific Finasteride Revenue Market Share by Region in 2020
Figure 62. China Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 63. China Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Japan Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 65. Japan Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 66. South Korea Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 67. South Korea Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 68. India Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 69. India Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Australia Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 71. Australia Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. Taiwan Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 73. Taiwan Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. Indonesia Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 75. Indonesia Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Thailand Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 77. Thailand Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. Malaysia Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 79. Malaysia Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Philippines Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 81. Philippines Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Vietnam Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 83. Vietnam Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Latin America Finasteride Sales Growth Rate 2016-2021 (MT)
Figure 85. Latin America Finasteride Revenue Growth Rate 2016-2021 (US$ Million)
Figure 86. Latin America Finasteride Sales Market Share by Country in 2020
Figure 87. Latin America Finasteride Revenue Market Share by Country in 2020
Figure 88. Mexico Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 89. Mexico Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 90. Brazil Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 91. Brazil Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Argentina Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 93. Argentina Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Middle East and Africa Finasteride Sales Growth Rate 2016-2021 (MT)
Figure 95. Middle East and Africa Finasteride Revenue Growth Rate 2016-2021 (US$ Million)
Figure 96. Middle East and Africa Finasteride Sales Market Share by Country in 2020
Figure 97. Middle East and Africa Finasteride Revenue Market Share by Country in 2020
Figure 98. Turkey Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 99. Turkey Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 100. Saudi Arabia Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 101. Saudi Arabia Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. U.A.E Finasteride Sales Growth Rate (2016-2021) (MT)
Figure 103. U.A.E Finasteride Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. Finasteride Value Chain
Figure 105. Channels of Distribution
Figure 106. Distributors Profiles
Figure 107. Bottom-up and Top-down Approaches for This Report
Figure 108. Data Triangulation
Figure 109. Key Executives Interviewed
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs